Stiripentol add‐on therapy for drug‐resistant focal epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Stiripentol Add‐on Therapy for Drug‐resistant Focal Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433636/1/Anticoagulation_for_the_long‐term_treatment_of_venous_thromboembolism_in_people_with_cancer_Edited__no_change_to_conclusions_. Accessed 19 April 2024.
Stiripentol add‐on therapy for drug‐resistant focal epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433636/1/Anticoagulation_for_the_long‐term_treatment_of_venous_thromboembolism_in_people_with_cancer_Edited__no_change_to_conclusions_. Accessed April 19, 2024.
Stiripentol add‐on therapy for drug‐resistant focal epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433636/1/Anticoagulation_for_the_long‐term_treatment_of_venous_thromboembolism_in_people_with_cancer_Edited__no_change_to_conclusions_
Stiripentol Add‐on Therapy for Drug‐resistant Focal Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433636/1/Anticoagulation_for_the_long‐term_treatment_of_venous_thromboembolism_in_people_with_cancer_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Stiripentol add‐on therapy for drug‐resistant focal epilepsy
ID - 433636
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433636/1/Anticoagulation_for_the_long‐term_treatment_of_venous_thromboembolism_in_people_with_cancer_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -